Synthetic Biology & Cleantech - Harvard Club of SF October 7, 2010

The Harvard Club of San Francisco will host an evening presentation and panel discussion with thought leaders at the intersection of synthetic biology and biofuels.

Microbiologist and bioinformatics expert Doug Hershberger, Ph.D. will moderate the panel of synthetic biology pioneers building synthetic bio alternatives to petroleum fuels and chemicals.

Confirmed panelists:

Robert Blazej, Ph.D. - Allopartis, Co-Founder & President. Allopartis Biotechnologies is a San Francisco-based startup developing tailored enzymes for the efficient conversion cellulosic biomass into fermentable sugars for renewable chemical and fuel production.

Jack D. Newman, Ph.D - Amyris, Co-Founder and Sr. VP Research. Amyris applies an industrial synthetic biology platform to provide high-performing alternatives to petroleum-sourced fuels and chemicals.

Stephen del Cardayre, Ph.D. - LS9, VP Research & Development. LS9 engineers a wide range of DesignerMicrobes(TM) used in a proprietary 1-step fermentation process to produce renewable fuels and sustainable chemicals.

Damien Perriman - Verdezyne, VP Business Development. Founded as a synthetic gene provider to the pharmaceutical and industrial enzyme businesses, Verdezyne focuses on fermentation pathway engineering for renewable fuels and chemicals.

Meet the cutting edge of synthetic biology and cleantech at the Harvard Club.

Email inquiries to Series Chair, Augie Rakow: [email protected]

The Cleantech Thought Leader Series introduces the Harvard Club community and guests to thought leaders working on the many front lines of clean energy technology.

Sponsor Orrick Herrington & Sutcliffe is a global law firm with 22 offices worldwide and specialized expertise in energy technology law.

Official Website: http://www.harvardclubsf.org/article.html?aid=220